Michael T. Tetzlaff

Pathological assessment of neoadjuvant‐treated melanoma specimens: a historical overview, lessons learned along the way and the road ahead

Neoadjuvant therapy has been recently established as the standard of care in surgically resectable stage III melanoma. Insofar as the extent of tumour response correlates with metrics of patient survival, this underscores the critical ongoing need for rigorous and reproducible ap...